Bacterial Persistence and Antimicrobial Therapy 2018

 

10th–14th, June 2018  - Congressi Stefano Franscini, Ascona, Switzerland -

Bacterial infections represent an increasingly urgent threat to human health worldwide with major pathogens being resistant to all available antibiotics. In addition, antibiotic therapy can fail to clear bacterial infections even in the absence of clinically detectable resistance. This is likely caused by drug-tolerant bacteria that survive even extensive exposure to antibiotics. The investigation of underlying mechanisms of microbial persistence and antibiotic tolerance is a newly emerging research field with already spectacular and fascinating insights.

The “Bacterial Persistence and Antimicrobial Therapy” Conference will bring together the world’s leading experts in this field using a variety of approaches.

 

Keynotes: Stewart ColeEPF Lausanne, CH
Bruce LevinEmory University, USA
Kim LewisNortheastern University, USA
Gisela StorzNational Institutes of Health, USA 
   
Confirmed Speakers:

Dan I AnderssonUppsala University, SE
Glenn DalePolyphor, CH
Petra DittrichETH Zürich, CH
Kenn GerdesCopenhagen University DK
Barbara KazmierczakYale University USA
Wolf-Dietrich HardtETH Zürich, CH
Matthias HeinemannGroningen University NL
Sophie HelaineImperial College London, UK
Terence Hwa - University of California San Diego, USA
Roy Kishoni - Israel Institute of Technology, IL
John McKinney - EPF Lausanne, CH
Jan Michiels - University of Leuven, BE
Laura Piddock - University of Birmingham, UK
Nathalie Questembert-Balaban - Hebrew University, IL 
Laurence Van Melderen - Bruxelles University, BE
Man-Wah Tan
Genentech, USA
Annelies Zinkernagel - University Hospital Zürich, CH

Follow us: